Showing results (351-360 of 458) with videos related to

Sort By:
Pageof 46
The Lancet. Oncology|July 30, 2013
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trialSusan G Kreissman, Robert C Seeger, Katherine K Matthay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2013
Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastomaJulieann Rader, Mike R Russell, Lori S Hart, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
BPTF cooperates with MYCN and MYC to link neuroblastoma cell cycle control to epigenetic cellular statesIrene Felipe, Jaime Martínez-de-Villarreal, Khushbu Patel, et al.
Cancer Chemotherapy and Pharmacology|March 31, 2011
Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancerHernan Carol, Ingrid Boehm, C Patrick Reynolds, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2017
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning MeetingJulie R Park, Rochelle Bagatell, Susan L Cohn, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Structural principles of peptide-centric Chimeric Antigen Receptor recognition guide therapeutic expansionYi Sun, Tyler J Florio, Sagar Gupta, et al.
Cancer Research|April 16, 2020
Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk NeuroblastomaBalakrishna Koneru, Gonzalo Lopez, Ahsan Farooqi, et al.
Science Immunology|December 1, 2023
Structural principles of peptide-centric chimeric antigen receptor recognition guide therapeutic expansionYi Sun, Tyler J Florio, Sagar Gupta, et al.
Pageof 46